Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT03040128

Use of Minocycline in Intracerebral Hemorrhage

Minocycline and Matrix Metalloproteinase Inhibition in Acute Intracerebral Hemorrhage: A Pilot Trial

Sponsor: University of Southern California

Interventions Minocycline normal saline infusion

Updated 6 times since 2017 Last updated: Jan 30, 2017 Started: Jun 27, 2013 Primary completion: Nov 30, 2016 Completion: Nov 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Intracerebral Hemorrhage and is currently completed. University of Southern California leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Mar 2023 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jan 2021 — Mar 2023 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

Feb 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Southern California
University of Tennessee

Data source: University of Tennessee

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.